First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study
| Image |  |
|---|---|
| Description | scientific article published on 10 January 2012 |
| Author/s |
author: Josep Tabernero Caturla Adelaida Lacasta Eduardo Díaz-Rubio |
| Publication date | January 10, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |